³Ô¹ÏÍøÕ¾

Latest

Latest chemotherapy News | Page 5

  • Latest chemotherapy news stories and updates. What is happening today? All recent chemotherapy news and developments. Live coverage and timeline of chemotherapy. All you need to know about chemotherapy.
Two incredible women talk about their parenting experiences on LiSTNR’s Dr Golly and the Experts
Tasmanians need more power price help 13 November 2023
Worried about getting a blood test? 5 tips to make them easier (and still accurate)
Perimenopause usually begins in your 40s. How do you know if it has started?
Immutep announces the completion of key stage of AIPAC-003 trial in metastatic breast cancer
Predicting cancer patient response to drugs that block DNA repair
Can Moving & Connecting Boost Your Mental Health After a Breast Cancer Diagnosis?
Dom’s Finding strength in being open about cancer
Public support needed to advance treatment in deadly brain cancers
Examining outcomes in children with Down syndrome and acute lymphoblastic leukemia
Broome champion becomes face of appeal to support country cancer patients
Clinical trials give Queensland breast cancer patients hope
The lives of a million children in Gaza hang in the balance as public health catastrophe looms
Breast cancer survivors urge women to get screened
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
‘We could see it happening before our eyes’: research shows how cancer cells resist chemotherapy
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer
Datopotamab deruxtecan plus Imfinzi demonstrated robust and durable tumour responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA…
Tagrisso plus chemotherapy reduced the risk of disease progression in the brain by 42% in patients with EGFR-mutated advanced lung cancer and…
Imfinzi plus chemotherapy more than doubled pathologic complete response rate in resectable early-stage gastric and gastroesophageal junction cancers versus chemotherapy alone
Blokes get breast cancer too, warns Ross
Alice Springs Hospital oncology and cardiology services supporting patients
Shoalhaven Cancer Care Centre 10-year milestone
Young and healthy mother warns ‘Breast Cancer doesn’t care if you’re pregnant’
Early breast cancer diagnosis is key
Manchester scientists investigate how to stop a more aggressive form of breast cancer spreading
After surviving her fifth cancer, Gayle is keen to give back and discovering the power of her story on others
Fibre boost could combat ‘chemo brain’ drain
Amy’s It all began with harmony test
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
£½ million funding announced to find new treatment for oesophageal cancer
Wollongong Hospital new-look Children’s Ward officially opens
NSW latest new-look Children’s Ward officially unveiled at Wollongong Hospital
New-look Children’s Ward officially unveiled at Wollongong Hospital
Scalp cooling machine to be back in action as soon as possible to assist Queenslanders undergoing cancer treatment
Scenic Rim’s fields of gold to support cancer research
Enhertu recommended for approval in the EU by CHMP for patients with HER2-mutant advanced non-small cell lung cancer
Brain cancer linked to nuclear pore alterations
Top Perth blood cancer researcher wins prestigious award
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
FivepHusion says first patient treated in paediatric brain cancer trial
Cultural custodian and knowledge holder Matthew Doyle unites with leading cancer charity to amplify the voices of First Nations people
Calquence approved in China for chronic lymphocytic leukaemia
Blood Cancer Awareness Month – Drew observes hospital life
Pharmaxis announces the publication of positive preclinical data for PXS-5505
Drug that targets scar-like tissue in tumours shows promise for pancreatic cancer

© 2024 - ³Ô¹ÏÍøÕ¾